Verified Nov 2026
Other
·

Novato, California
·
Since 2010
Ultragenyx is a biopharmaceutical company founded in 2010 and headquartered in Novato, California, with 1,000–5,000 employees and estimated revenue of $500 million to $1 billion. The company develops therapies for rare and ultra-rare genetic diseases across multiple modalities, including enzyme replacement therapies, gene therapies, and small molecules. It markets four approved products for conditions such as X-linked hypophosphatemia and mucopolysaccharidosis VII, and operates research and manufacturing facilities across the United States, Mexico, Colombia, Spain, and the United Kingdom.
Ultragenyx at a glance
Revenue
$500M-1B
Est. band
Employees
1,000-5,000
Founded
2010
Headquarters
Novato, California
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Ultragenyx is a biopharmaceutical company founded in 2010 and headquartered in Novato, California, with 1,000–5,000 employees and estimated revenue of $500 million to $1 billion. The company develops therapies for rare and ultra-rare genetic diseases across multiple modalities, including enzyme replacement therapies, gene therapies, and small molecules. It markets four approved products for conditions such as X-linked hypophosphatemia and mucopolysaccharidosis VII, and operates research and manufacturing facilities across the United States, Mexico, Colombia, Spain, and the United Kingdom.
At a glance
Attribute | Detail |
|---|---|
Founded | 2010 |
Headquarters | Novato, California |
Employees | 1,000-5,000 |
Revenue | $500M-1B (estimated) |
What Ultragenyx makes
The company's portfolio includes monoclonal antibodies, enzyme replacement therapies, small molecules, antisense oligonucleotides, mRNA therapies, and gene therapies targeting genetic disorders with high unmet medical needs.
Latest developments
2026-11-16 — Ultragenyx at UBS biopharma conference: growth plan after setbacks By Investing.com (investing.com)
2026-11-03 — Ultragenyx Reports Third Quarter 2026 Financial Results, Announces Substantial Expense Reductions, and Reaffirms Profitability in 2027—Ultragenyx Pharmaceutical Inc. (ultragenyx.com)
2026-10-14 — Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $203 Million—Ultragenyx Pharmaceutical Inc. (ultragenyx.com)
2026-07-02 — ACD ENTERS AGREEMENT WITH ULTRAGENYX TO INVEST IN CLINICAL DEVELOPMENT OF THERAPY FOR CREATINE TRANSPORTER DEFICIENCY (einpresswire.com)
2026-05-05 — Ultragenyx Reports First Quarter 2026 Financial Results and Corporate Update—Ultragenyx Pharmaceutical Inc. (ultragenyx.com)
2026-01-12 — Ultragenyx Provides Financial and Business Updates at J.P. Morgan Annual Healthcare Conference—Ultragenyx Pharmaceutical Inc. (ultragenyx.com)
Facilities
Ultragenyx is headquartered in Novato, California. Public sources also reference these locations:
Bedford, Massachusetts — ultragenyx.com
Company details
Ultragenyx operates in 12 countries and maintains significant clinical and manufacturing infrastructure, with facilities including operations in Bedford, Massachusetts. Ultragenyx was founded in 2010, has an estimated 1,000-5,000 employees, and is headquartered in Novato, California.
Frequently asked questions
What does Ultragenyx do?
Ultragenyx is a biopharmaceutical company founded in 2010 and headquartered in Novato, California, with 1,000–5,000 employees and estimated revenue of $500 million to $1 billion. The company develops therapies for rare and ultra-rare genetic diseases across multiple modalities, including enzyme replacement therapies, gene therapies, and small molecules. It markets four approved products for conditions such as X-linked hypophosphatemia and mucopolysaccharidosis VII, and operates research and manufacturing facilities across the United States, Mexico, Colombia, Spain, and the United Kingdom.
Where is Ultragenyx headquartered?
Ultragenyx is headquartered in Novato, California (60 Leveroni Court, Novato, California, 94949).
When was Ultragenyx founded?
Ultragenyx was founded in 2010.
How big is Ultragenyx?
Ultragenyx has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
